P E Postmus
Overview
Explore the profile of P E Postmus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
338
Citations
4313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuipers M, Van Doorn-Wink K, Postmus P
Heliyon
. 2024 Jul;
10(14):e34345.
PMID: 39082015
Radiation induced pneumonitis is a common side effect of thoracic radiotherapy. We report a case of a patient diagnosed with symptomatic radiation pneumonitis and a serious contra-indication for corticosteroids. For...
2.
de Graaf M, Antoni M, Ter Kuile M, Arbous M, Duinisveld A, Feltkamp M, et al.
EClinicalMedicine
. 2021 Feb;
32:100731.
PMID: 33532720
Background: Short-term follow-up of COVID-19 patients reveals pulmonary dysfunction, myocardial damage and severe psychological distress. Little is known of the burden of these sequelae, and there are no clear recommendations...
3.
Thunnissen E, Lissenberg-Witte B, van den Heuvel M, Monkhorst K, Skov B, Sorensen J, et al.
Lung Cancer
. 2019 Oct;
138:13-18.
PMID: 31630043
Objective: Metastasized non-small cell lung cancer (NSCLC) with an anaplastic lymphoma kinase (ALK) rearrangement is usually sensitive to a range of ALK-tyrosine kinase inhibitors. ALK-positive NSCLC have been identified in...
4.
Postmus P, Kerr K, Oudkerk M, Senan S, Waller D, Vansteenkiste J, et al.
Ann Oncol
. 2017 Sep;
28(suppl_4):iv1-iv21.
PMID: 28881918
No abstract available.
5.
Kuiper J, Hashemi S, Thunnissen E, Snijders P, Grunberg K, Bloemena E, et al.
Br J Cancer
. 2016 Nov;
115(12):1504-1512.
PMID: 27875527
Background: Data on non-small-cell lung cancer (NSCLC) patients with non-classic epidermal growth factor receptor (EGFR) mutations are scarce, especially in non-Asian populations. The purpose of this study was to evaluate...
6.
Johannesma P, van de Beek I, van der Wel J, Paul M, Houweling A, Jonker M, et al.
Springerplus
. 2016 Sep;
5(1):1506.
PMID: 27652079
Background And Objectives: Birt-Hogg-Dubé syndrome is an autosomal dominant disorder characterized by skin fibrofolliculomas, lung cysts, spontaneous pneumothorax and renal cell cancer due to germline folliculin (FLCN) mutations (Menko et...
7.
Hendriks L, Derks J, Postmus P, Damhuis R, Houben R, Troost E, et al.
Eur J Cancer
. 2015 Sep;
51(17):2534-44.
PMID: 26323530
Purpose: To analyse the prognostic impact on overall survival (OS) of single versus multiple organ metastases, organ affected, and local disease status in a population based stage IV non-small cell...
8.
Hubers A, Heideman D, Burgers S, Herder G, Sterk P, Rhodius R, et al.
Br J Cancer
. 2015 Feb;
112(6):1105-13.
PMID: 25719833
Background: Lung cancer has the highest mortality of all cancers. The aim of this study was to examine DNA hypermethylation in sputum and validate its diagnostic accuracy for lung cancer....
9.
Gan C, Vonk Noordegraaf A, Marques K, Bronzwaer J, Postmus P, Boonstra A
Neth Heart J
. 2015 Feb;
12(7-8):337-342.
PMID: 25696358
Medical therapy for pulmonary arterial hypertension (PAH) focuses on pulmonary vascular remodelling and smooth muscle cell proliferation. This article covers the drugs which are approved or are in sight and...
10.
Gan C, Vonk Noordegraaf A, Marques K, Bronzwaer J, Postmus P, Boonstra A
Neth Heart J
. 2015 Feb;
12(6):287-294.
PMID: 25696347
Pulmonary arterial hypertension (PAH) is a disease characterised by an increased pulmonary artery pressure. The precapillary pulmonary arteries show distinct pathobiological changes, i.e. medial hypertrophy, intimal fibrosis, microthrombi and plexiform...